This is an old revision of the document!
Lytica Therapeutics
Lytica Therapeutics is an American biotechnology company based in Cambridge, Massachusetts.
History
On February 18, 2020, Lytica was awarded a $16.9 million grant from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) for a project to “develop antibacterial peptides with broad activity against multidrug-resistant bacteria.”1) 2)
Organization
Personnel
| Lytica Therapeutics - Team | ||
|---|---|---|
| Name | Position | Notes |
| Loren Walensky | Scientific Co-founder3) | Husband of Rochelle Walensky; employed at Dana-Farber Cancer Institute |
External links
1)
Robinson, J., & Finnegan, A. (2020, April 18). CARB-X funds Lytica Therapeutics to develop antibacterial peptides to treat drug-resistant infections in the lungs and other parts of the body. CARB-X. http://archive.today/2021.08.08-003713/https://carb-x.org/carb-x-news/carb-x-funds-lytica-therapeutics-to-develop-antibacterial-peptides-to-treat-drug-resistant-infections-in-the-lungs-and-other-parts-of-the-body/
2)
Hounsell, S. (2021, August 6). EXCLUSIVE: CDC Director Walensky’s Husband Received $5 Million in HHS Grants - and That’s Just the Start of It. RedState. https://web.archive.org/web/20230110204450/https://redstate.com/scotthounsell/2021/08/06/exclusive-cdc-director-walenskys-husband-received-5-million-in-hhs-grants-and-thats-just-the-start-of-it-n421809
3)
Loren Walensky. Lytica Therapeutics. Retrieved February 3, 2023, from https://web.archive.org/web/20230203130106/https://lyticatherapeutics.com/loren-walensky